Companies: 10,795·Total market cap: $144.5T
Caliber Imaging & Diagnostics, Inc.

Caliber Imaging & Diagnostics, Inc.

LCDXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$5104
P/E Ratio
52W High$0.0008
52W Low$0.0001

Caliber Imaging & Diagnostics, Inc. (LCDX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lcdx · pe ratio · data through Dec 31, 2013

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Caliber Imaging & Diagnostics, Inc. (LCDX) measures how much investors pay for each dollar of the company's trailing earnings. LCDX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.65.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2013-12-31

Forward P/E
N/A
EPS (TTM)
-$0.65
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Caliber Imaging & Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2009 – 2013 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Caliber Imaging & Diagnostics, Inc.
Caliber Imaging & Diagnostics, Inc.You
LCDX
$0MN/A-$0.65
New York Health Care, Inc.
New York Health Care, Inc.
BBAL
$0MN/A-$0.03
FluoroPharma Medical, Inc.
FluoroPharma Medical, Inc.
FPMI
$0MN/A-$0.06
Longport, Inc.
Longport, Inc.
LPTI
$0MN/A
Nemaura Medical Inc.
Nemaura Medical Inc.
NMRD
$0MN/A-$0.57
Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc.
NMXS
$0MN/A-$0.05
NewCardio, Inc.
NewCardio, Inc.
NWCI
$0MN/A-$0.40

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2013-12-31Latest
FY2013
$-0.65
2012-12-31
FY2012
$-1.23
2011-12-31
FY2011
$-4.18
2010-12-31
FY2010
$-1.99
2009-12-31
FY2009
$-1.87

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Caliber Imaging & Diagnostics, Inc. (LCDX) measures how much investors pay for each dollar of the company's trailing earnings. LCDX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.65.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.65 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

LCDX pe ratio · 6 questions

LCDX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.65. Data sourced from Financial Modeling Prep via LCDX's SEC 10-K and 10-Q filings.

LCDX PE ratioWhat is LCDX PE ratioCurrent PE ratio of LCDXLCDX PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Caliber Imaging & Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09